Podcast 29 Nov 2024
Can biotech beat mosquito-borne diseases?
With mosquito-borne diseases on the rise, Oxitec’s Friendly mosquitoes are designed to suppress populations of disease-spreading mosquitoes.
- Latest Posts
Best in Biotech 28 Nov 2024
Six antisense oligonucleotide companies shaping the future of genetic medicine
Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is expected to grow.
In Depth 27 Nov 2024
Charcot–Marie–Tooth disease: what’s going on in the clinical field?
In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.
Best in Biotech 26 Nov 2024
Seven miRNA-focused companies pioneering new therapies in 2024
Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration.
Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success
Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of cancer treatment.
News and Trends 25 Nov 2024
Evotec on the brink of acquisition: At what cost for the biotech industry?
As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape.
ADVERTISEMENT
ADVERTISEMENT
In Depth 22 Nov 2024
Can AlphaFold3’s open-source platform revolutionize the way we discover drugs?
Find out how Google DeepMind’s AlphaFold3 platform could help scientists revolutionize the field of drug discovery.
Podcast 22 Nov 2024
Could antigen modulation address autoimmune diseases?
To tell us more about antigen modulation this week is Pete Joyce, CEO and co-founder of Grey Wolf Therapeutics.
In Depth 21 Nov 2024
Huntington’s disease: a therapeutic field on a bumpy ride
For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.
Best in Biotech 21 Nov 2024
Eight areas where gene therapy shines
Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases.
In Depth 20 Nov 2024
Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024
The hypoparathyroidism treatment space has made quite a buzz this year with a major drug approval, acquisition, and significant advances in clinical trials.
Best in Biotech 19 Nov 2024
Six bispecific antibody companies you should know about
Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.
ADVERTISEMENT
